The goal of this clinical trial is to learn if a video-guided mindfulness intervention can improve prenatal depression symptoms, improve mental health-related quality of life, reduce the risk of maternal postpartum depression and paternal postpartum depression, and improve neonatal birth outcomes in a resource-constrained setting. This clinical trial will be conducted in pregnant women. The main questions it aims to answer are:
* Can video-guided mindfulness intervention be effective for prenatal depression treatment as compared to routine care? * Is there a dose-response relationship between the length of a video-guided mindfulness intervention and a reduction in prenatal depression symptoms? * Does a video-guided mindfulness intervention improve mental health-related quality of life more effectively than routine care? * What is the impact of intervention duration on the effectiveness of a video-guided mindfulness intervention for improving mental health-related quality of life? * Can a video-guided mindfulness intervention during pregnancy lead to improved neonatal birth outcomes compared to standard care? * Can a video-guided mindfulness intervention during pregnancy reduce the risk of developing prenatal depression compared to routine care? * Can the treatment of maternal prenatal depression through a video-guided mindfulness intervention reduce the risk of paternal postpartum depression? Researchers will compare the intervention group with a group of pregnant women who screen positive for prenatal depression but continue to receive only routine antenatal care, in order to evaluate differences in prenatal depression symptoms, improvements in mental health-related quality of life, reductions in the risk of maternal and paternal postpartum depression, and improvements in neonatal birth outcomes.
Participants (the intervention group) will receive a video-guided mindfulness intervention that they will listen to for eight weeks at their nearest health center three times a week.
Pregnant women who lived in Jimma City for at least six months
Women with a gestational age between 12 and 28 weeks,
Women who scored EPDS ≥ 13,
Willing to participate for eight consecutive weeks,
Having been diagnosed with mental health disorders or eating disorders,
Active substance use,
EPDS item 10 score ≥1 or total EPDS score >19,
Currently receiving pharmacological or psychotherapeutic treatment,